CA2596799A1 - Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer - Google Patents
Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer Download PDFInfo
- Publication number
- CA2596799A1 CA2596799A1 CA002596799A CA2596799A CA2596799A1 CA 2596799 A1 CA2596799 A1 CA 2596799A1 CA 002596799 A CA002596799 A CA 002596799A CA 2596799 A CA2596799 A CA 2596799A CA 2596799 A1 CA2596799 A1 CA 2596799A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- aralkyl
- heteroaryl
- aryl
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64947005P | 2005-02-02 | 2005-02-02 | |
US60/649,470 | 2005-02-02 | ||
PCT/US2006/003817 WO2006084116A2 (fr) | 2005-02-02 | 2006-02-02 | Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2596799A1 true CA2596799A1 (fr) | 2006-08-10 |
Family
ID=36777960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002596799A Abandoned CA2596799A1 (fr) | 2005-02-02 | 2006-02-02 | Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1845985A4 (fr) |
JP (1) | JP2008528697A (fr) |
AU (1) | AU2006210537A1 (fr) |
CA (1) | CA2596799A1 (fr) |
WO (1) | WO2006084116A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926297B1 (fr) | 2008-01-10 | 2013-03-08 | Centre Nat Rech Scient | Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage. |
EP3120863B1 (fr) * | 2008-02-29 | 2020-05-06 | Acorda Therapeutics, Inc. | Compositions permettant de fournir les niveaux de plasma désirés du facteur 2 de croissance gliale |
EP2505198A1 (fr) | 2011-04-01 | 2012-10-03 | Société Splicos | Composés pour leur utilisation en tant qu'agents thérapeutiques affectant l'expression et/ou l'activité de p53 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750348B1 (en) * | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
US6369226B1 (en) * | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
WO2002100846A1 (fr) * | 2001-06-11 | 2002-12-19 | Shire Biochem Inc. | Composes et methodes de traitement ou de prevention d'infections a flavivirus |
US20050228017A1 (en) * | 2001-10-31 | 2005-10-13 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Novel anticancer compounds |
US20040166137A1 (en) * | 2002-11-08 | 2004-08-26 | Lackey John William | Hetero-substituted benzimidazole compounds and antiviral uses thereof |
-
2006
- 2006-02-02 WO PCT/US2006/003817 patent/WO2006084116A2/fr active Application Filing
- 2006-02-02 EP EP06734275A patent/EP1845985A4/fr not_active Withdrawn
- 2006-02-02 CA CA002596799A patent/CA2596799A1/fr not_active Abandoned
- 2006-02-02 AU AU2006210537A patent/AU2006210537A1/en not_active Abandoned
- 2006-02-02 JP JP2007554235A patent/JP2008528697A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1845985A4 (fr) | 2011-10-12 |
EP1845985A2 (fr) | 2007-10-24 |
AU2006210537A1 (en) | 2006-08-10 |
WO2006084116A2 (fr) | 2006-08-10 |
JP2008528697A (ja) | 2008-07-31 |
WO2006084116A3 (fr) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109153640B (zh) | 用抗病毒剂消除乙型肝炎病毒 | |
Tan et al. | Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1, 3, 4]-oxadiazoles as potential anti-hepatitis B virus agents | |
CN103561576B (zh) | 脂质合成的杂环调节剂 | |
CN110023304A (zh) | 钙蛋白酶调节剂及其治疗用途 | |
CN108348529A (zh) | 乙型肝炎核心蛋白调节剂 | |
US9168269B2 (en) | Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals | |
KR20090018593A (ko) | 세포괴사 저해제로서의 인돌 및 인다졸 화합물 | |
CA2810706C (fr) | Amide substitue | |
US20150139949A1 (en) | Anti-viral combination therapy | |
US7705021B2 (en) | Isoindolone compounds, compositions containing the same, and methods of use thereof for the treatment of viral infections related to the etiology of cancer | |
WO2011106627A1 (fr) | Acides hydroxamiques substitués et leurs utilisations | |
BRPI0413430B1 (pt) | Derivados de amida os um sal destes, composição farmacêutica compreendendo os mesmos e uso destes para o tratamento de doenças em que está implicado o Herpesvírus. | |
CN110177551A (zh) | 脂质合成的杂环调节剂 | |
CA2596799A1 (fr) | Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer | |
JP6041877B2 (ja) | キナゾリノン類似体及び特定のウイルス感染症の治療又は予防へのキナゾリノン類似体の使用 | |
WO2006082821A1 (fr) | Agent preventif ou therapeutique contre une maladie liee au virus de l'herpes | |
CA2881901C (fr) | Carboxamides heterocyclyle pour le traitement de maladies virales | |
CN117255686A (zh) | Vps34抑制剂的抗病毒活性 | |
JP2023550638A (ja) | ウイルス感染症の処置に使用するための、vsp34阻害剤としてのモルホリノ誘導体 | |
CN117241800A (zh) | Vps34抑制剂的抗病毒活性 | |
JP2023550641A (ja) | ウイルス感染症の治療に使用するためのvsp34阻害剤としてのモルホリノ誘導体 | |
JP2023550640A (ja) | Vps34阻害剤の抗ウイルス活性 | |
JP2023553809A (ja) | ウイルス感染の治療に使用するためのvsp34阻害剤としてのピリジルピリドン誘導体 | |
JP2003063993A (ja) | 医薬組成物 | |
CN111407767B (zh) | 一种磺胺间甲氧嘧啶衍生物在制备抗肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |